Neurotoxicity: Clinical Trials

2 trials for Neurotoxicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 21Completed 1

Follow Neurotoxicity: new trials by email Literature Review of Neurotoxicity trials Research Report on Neurotoxicity

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
glucarpidase, leucovorin calcium, methotrexate - Chemotherapeutic Agent Toxicity, Lymphoma
Phase 1 / Phase 2CompletedUniversity College, London42008-07-012014-01-27
Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases
lithium carbonate, cognitive assessment, quality-of-life assessment - Brain and Central Nervous System Tumors, Cognitive/Functional Effects
Phase 1TerminatedVanderbilt-Ingram Cancer Center92006-02-012012-02-28

Narrower conditions

Neurotoxicity Syndromes (2)  ·  Brain Neoplasms (1)  ·  Central Nervous System Neoplasms (1)  ·  Lymphoma (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Mucositis (1)  ·  Radiation Injuries (1)

Broader conditions

Chemically-Induced Disorders (2)  ·  Neoplasms (2)  ·  Nervous System Diseases (2)  ·  Poisoning (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Digestive System Diseases (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)

Interventions

Radiotherapy (2)  ·  Leucovorin (1)  ·  Lithium (1)  ·  Lithium Carbonate (1)  ·  Mental Status and Dementia Tests (1)  ·  Methotrexate (1)  ·  glucarpidase (1)

Sponsors

University College, London (1)  ·  Vanderbilt-Ingram Cancer Center (1)

Countries

United Kingdom (1)  ·  United States (1)

Top investigators

Bo Lu, MD, PhD (1)  ·  Roderick Johnson, MD (1)